IRIS
VALENSISE, HERBERT CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.365
AS - Asia 3.827
EU - Europa 2.765
SA - Sud America 557
AF - Africa 58
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 23.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.227
SG - Singapore 2.130
IT - Italia 883
CN - Cina 678
BR - Brasile 438
RU - Federazione Russa 381
DE - Germania 290
VN - Vietnam 285
IE - Irlanda 229
HK - Hong Kong 210
FR - Francia 172
UA - Ucraina 150
GB - Regno Unito 140
FI - Finlandia 124
PL - Polonia 122
JP - Giappone 109
NL - Olanda 87
BD - Bangladesh 83
CA - Canada 73
SE - Svezia 70
IN - India 67
AR - Argentina 46
KR - Corea 38
ID - Indonesia 37
IQ - Iraq 31
MX - Messico 31
CZ - Repubblica Ceca 28
ES - Italia 26
TR - Turchia 26
ZA - Sudafrica 18
PS - Palestinian Territory 17
EC - Ecuador 16
AU - Australia 15
CO - Colombia 15
PK - Pakistan 15
AT - Austria 13
NP - Nepal 12
VE - Venezuela 12
MY - Malesia 11
BE - Belgio 10
CL - Cile 10
AE - Emirati Arabi Uniti 8
JM - Giamaica 8
MA - Marocco 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
IL - Israele 7
EG - Egitto 6
GT - Guatemala 6
IR - Iran 6
PE - Perù 6
PY - Paraguay 6
AZ - Azerbaigian 5
BO - Bolivia 5
DZ - Algeria 5
HN - Honduras 5
KZ - Kazakistan 5
LT - Lituania 5
PH - Filippine 5
HR - Croazia 4
JO - Giordania 4
KE - Kenya 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HU - Ungheria 3
LB - Libano 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
SV - El Salvador 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CG - Congo 2
CI - Costa d'Avorio 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
EU - Europa 1
GD - Grenada 1
GI - Gibilterra 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 23.581
Salva come PNG Salva come JPEG
Città #
Wilmington 3.897
Houston 3.497
Woodbridge 3.392
Singapore 788
Fairfield 526
Ashburn 482
San Jose 416
Chandler 370
Ann Arbor 276
Dublin 230
Rome 226
Beijing 211
Seattle 210
Hong Kong 202
Council Bluffs 180
New York 179
Cambridge 165
Medford 151
Los Angeles 139
Santa Clara 130
Jacksonville 114
The Dalles 110
Ho Chi Minh City 106
Kraków 104
Zhengzhou 98
Tokyo 88
Helsinki 84
Dearborn 79
Boardman 76
Lawrence 69
Milan 65
Hanoi 64
Lauterbourg 56
Buffalo 54
Dallas 54
Moscow 48
São Paulo 48
North Bergen 46
Cedarhurst 38
San Diego 34
Redondo Beach 30
Chicago 28
Frankfurt am Main 26
London 26
Montreal 25
Olomouc 25
Naples 24
Shanghai 23
Chennai 22
Orem 22
Phoenix 22
Amsterdam 21
Atlanta 21
Florence 21
Munich 21
Manchester 20
Monte Vista 18
Mülheim 18
Turin 18
Brooklyn 17
Denver 17
Dhaka 17
Baghdad 14
Bologna 14
Boston 14
Nanjing 14
San Francisco 14
Guangzhou 13
Nuremberg 13
Poplar 13
Stockholm 13
Vancouver 13
Johannesburg 12
Palermo 12
Utrecht 12
Ankara 11
Rio de Janeiro 11
Warsaw 11
Brussels 10
Columbus 10
Jakarta 10
Mexico City 10
Salt Lake City 10
Da Nang 9
Genoa 9
Lappeenranta 9
Menlo Park 9
Norwalk 9
Seoul 9
Toronto 9
Ascoli Piceno 8
Campinas 8
City of London 8
Curitiba 8
Hefei 8
Melbourne 8
Querétaro 8
Quito 8
Redwood City 8
Suzhou 8
Totale 17.981
Salva come PNG Salva come JPEG
Nome #
Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications 550
Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function 547
Body composition during normal pregnancy: reference ranges 521
Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction 505
Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies 500
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 483
Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia 482
Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: Relationship to placenta-related complications of pregnancy 476
Could birthweight prediction models be improved by adding fetal subcutaneous tissue thickness? 461
Molecular basis of thyrotropin and thyroid hormone action during implantation and early development 455
Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancy 449
PP065. Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy in order to predict hypertensive complications 437
Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach 436
Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer 435
Maternal total vascular resistance and concentric geometry: A key to identify uncomplicated gestational hypertension 435
Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery 432
The computerized fetal heart rate analysis in post-term pregnancy identifies patients at risk for fetal distress in labour 425
Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. 422
Molecular basis of thyrotropin and thyroid hormone action during implantation and early development 415
Ultrasound-determined fetal subcutaneous tissue thickness for a birthweight prediction model 412
Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin 405
Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension 401
Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients 399
Normal fetal growth in women with antiphospholipid syndrome treated with high dose intravenous immunoglobulins 395
Nifedipine-induced changes in body composition in hypertensive patients at term 390
The fetal body compartments and their detection during pregnancy. A review 383
GSTA1 gene variation associated with gestational hypertension and its involvement in pregnancy-related pathogenic conditions 374
Maternal body composition at term gestation and birth weight: is there a link? 362
Total body water estimation and maternal cardiac systolic function assessment in normal and gestational hypertensive pregnant women 358
Adjuvant vemurafenib in resected, BRAFV600mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial 355
Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women 352
Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study 295
Foetal heart rate deceleration with combined spinal-epidural analgesia during labour: A maternal haemodynamic cardiac study 276
The influence of doctor-patient and midwife-patient relationship in quality care perception of Italian pregnant women: An exploratory study 262
Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Pre-Eclampsia and Italian Society of Perinatal Medicine 232
Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders 197
Assessment of venous hemodynamics and volume homeostasis during pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 196
Early and Late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease 193
Maternal hemodynamics early in labor: a possible link with obstetric risk? 192
Fetal growth restriction and maternal cardiac function 188
Assessment of arterial function in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 185
Clinical opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach 184
The maternal cardiovascular effect of carbetocin compared to oxytocin in women undergoing caesarean section 182
Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials 182
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 179
Antenatal Care of Preeclampsia: From the Inverted Pyramid to the Arrow Model? 174
Ultrasonographic evaluation of the second stage of labor. Predictive parameters for a successful vaginal delivery with or without neuraxial analgesia: a pilot study 172
Severe fetal growth restriction at 26–32 weeks: key messages from the TRUFFLE study 171
Research priorities for the future health of multiples and their families: The Global Twins and Multiples Priority Setting Partnership 169
Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics 168
Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind? 168
Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction? 168
The Impact of Kidney Development on the Life Course: A Consensus Document for Action 163
Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure 159
Chronic pain management in pregnancy and lactation 158
Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth 157
Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy? 156
Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome 155
Friendly help for clinical use of maternal hemodynamics 154
Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease 150
Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent preeclampsia 148
Acetylsalicylic acid in pregnant women with chronic hypertension 147
Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe 146
Functional hemodynamic testing in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 145
Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True? 145
Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: Study protocol for a randomized controlled trial 145
Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics 137
Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction 132
Circulating EGFL7 distinguishes between IUGR and PE: an observational case–control study 131
Preeclampsia: the role of persistent endothelial cells in uteroplacental arteries. Brosens I, Brosens JJ, Muter J, Puttemans P, Benagiano G. Am J Obstet Gynecol 2019;221:219-26 130
Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study 127
The “Preeclampsia and Hypertension Target Treatment” (“PYTT”) study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings 117
Prenatal and postnatal imaging of multiple intracranial lipomas: Report of a Case 117
Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction 109
A practical approach to the management of thyroid dysfunction during pregnancy 108
Are Chlamydia Trachomatis and Neisseria Gonorrhoeae Screenings in Pregnant Women Being Properly Performed? A Single-Center Retrospective Observational Study in Italy 106
Systemic vascular resistance may influence the outcome of in vitro fertilization 105
Cardiac Function 103
Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study 103
D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients 93
Maternal Cardiovascular Dysfunction is Associated with Hypoxic Cerebral and Umbilical Doppler Changes 92
F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy? 90
The p63 C-terminus is essential for murine oocyte integrity 90
Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction 89
Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction 89
G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 86
Definition, identification, implications and management of hypodynamic hypertension in pregnancy 85
Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM) 85
Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction 79
Cell immunity and recurrent miscarriage 76
Are HLA-G polymorphisms associated to recurrent pregnancy loss? 76
Restricted physical activity and maternal rest improve fetal growth: should we look for the reason in the cardiovascular modifications? 76
C-peptide and insulin levels at 24-30 weeks' gestation: An increased risk of adverse pregnancy outcomes? 73
SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia 71
Maternal hemodynamics in early and late fetal growth restriction 71
G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles 71
Phenotypic characterization of the placenta from women with Multiple Sclerosis exposed to Natalizumab during pregnancy. 67
Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies 66
ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction 65
NO donors on top of anti-hypertensive therapy reduces complications in chronic hypertensive pregnancies with hypodynamic circulation 64
Totale 22.892
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.928
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022692 32 96 34 36 19 34 43 32 45 83 44 194
2022/20231.102 149 93 34 108 106 230 95 83 112 18 61 13
2023/2024434 52 8 11 10 27 115 26 13 10 18 11 133
2024/20253.348 37 407 225 104 63 392 310 153 356 183 621 497
2025/20265.228 359 186 565 599 533 232 567 664 535 418 313 257
Totale 23.991